The Citalopram for Agitation in Alzheimer Disease Study ( CitAD ) was a randomized , placebo-controlled , double-blind , parallel group trial that enrolled @ patients with probable Alzheimer disease and clinically significant agitation from @ academic centers in the United States and Canada from August @ to January @ .